Skip to main content
. 2016 Mar 23;12:60. doi: 10.1186/s12917-016-0687-7

Table 1.

Demographic variables and outcome measures in the first clinical baseline examination of the placebo and NASHA groups (n = 27) and P-values for the comparison between treatment groups at the first clinical baseline examination

Variable Placebo NASHA P-value
Number of horses 13 14
Age (~years): Mean (range) 8.4 (4–17) 7.2 (4–12) 0.55
Gender: Mare/Stallion/Gelding % 46 %/15 %/39 % 43 %/21 %/36 % 0.09
Purpose: Harness race horse/Riding horse % 54 %/46 % 71 %/29 % 0.44
Breed: Standardbred/Finnhorse/Wamblood/Pony % 31 %/39 %/15 %/15 % 43 %/50 %/7 %/0 % 0.65
Affected limb: RF/LF % 46 %/54 % 71 %/29 % 0.25
Baseline lameness (AAEP)a: 0/1/2/3/4/5 % 0 %/15 %/39 %/46 %/0 %/0 % 0 %/36 %/57 %/7 %/0 %/0 % 0.05
Effusionb: 0/1/2/3/4 % 23 %/46 %/0 %/31 %/0 % 29 %/29 %/35 %/7 %/0 % 0.83
Lameness in the flexion testc: 0/1/2/3/4 % 0 %/0 %/8 %/61 %/31 % 0 %/0 %/29 %/50 %/21 % 0.33
Pain in flexiond: 0/1/2/3 % 0 %/31 %/23 %/46 % 7 %/29 %/36 %/28 % 0.46
Mild findings in radiographs: Yes/No % 54 %/46 % 50 %/50 % 1.00

a AAEP scale 0–5

b 0 = no effusion, 1 = mild, 2 = moderate, 3 = severe effusion, 4 = severe swelling of the metacarpal joint region

c 0 = no increase, 1 = slight increase, 2 = moderate increase, 3 = considerable increase in baseline lameness, 4 = non-weight-bearing lameness

d 0 = no pain at flexion, 1 = mild pain, 2 = moderate pain, 3 = severe pain